CCM Therapy for Chronic Heart Failure – Virtual Conference
Cardiac contractility modulation (CCM) therapy is a new innovation in the treatment of symptomatic chronic heart failure patients who have a reduced left ventricular ejection fraction, who are in normal sinus rhythm and not candidates for cardiac resynchronization therapy. This therapy has been shown to reduce symptoms and improve quality of life while reducing the risk of hospitalization from decompensated heart failure. In this video conference, we will discuss the benefits of CCM therapy, the mechanism of action by which this therapy improves clinical outcomes, indications, and implantation technique. We will discuss the evidence that supports the use of this therapy in chronic heart failure.
Practicing cardiologists in South Western Pennsylvania, cardiovascular disease fellows, cardiovascular advanced practice providers, electrophysiologists, heart failure specialists, heart failure nurses, pharmacists
Matthew Lander, MD
Srinivas Murali, MD
George Shaw, MD
Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Allegheny General Hospital designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance